This site (as well as many other sites on the web) uses Adobe Flash Player. Please download Flash Player to enhance your experience of this website.
Your contribution will help doctors and scientists all over the world to bring an end to diabetes of all types. Together we can brighten the lives of people across the globe.
he role of my laboratory in the CDP is to provide lentivectors that are used to perform genetic engineering of cells. Lentivectors are microscopic particles derived from lentiviruses. Our knowledge of their life cycle has helped us taming them in such a way that they can no longer achieve . . .
Rafael Vega, Ph.D. was awarded the 2010 Genentech Presidential Student Mentor Award from the American Society of Transplant Surgeons for his research in gold nanoparticles. . .
“I was diagnosed with Type I Diabetes just a few months after my 37th birthday and have battled the disease for 15 years. My blood sugar levels would elevate past 600 mg/dl and then drop below 17 mg/dl several times . . .